SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Oxygen Biotherapeutics, Inc.’ Update on US Army-Funded Preclinical Studies Designed to Support the Safety Profile of Oxycyte PFC Emulsion Currently in Clinical Trials Overseas for Traumatic Brain Injury